Please note that the Lippincott Web site makes extensive use of CSS for layout throughout the site. You are seeing this message because your browser does not comply with modern web standards, or you are using a device that does not support the more advanced properties of CSS. Please click here to learn more about this issue, and for links to upgrade your browser.
Aptuit

End-to-End Innovation 


Global Pharmaceutical Development, Inc. was an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators. This company name was intended to be a placeholder while private equity financing was underway. Lippincott Mercer was engaged to rapidly create a new corporate name and identity to visually and linguistically represent the mission and vision of the company before its first acquisition was announced.

The name Aptuit captures the human qualities of intelligence and insight that are required to deliver our vision to engineer a better drug development process to more efficiently achieve milestones for our pharmaceutical and biotech customers.

Michael A. Griffith

CEO, Aptuit

Challenges

Actions

» see news release